GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » EV-to-EBITDA

Vineet Laboratories (BOM:543298) EV-to-EBITDA : 9.77 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vineet Laboratories's enterprise value is ₹875 Mil. Vineet Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹90 Mil. Therefore, Vineet Laboratories's EV-to-EBITDA for today is 9.77.

The historical rank and industry rank for Vineet Laboratories's EV-to-EBITDA or its related term are showing as below:

BOM:543298' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.81   Med: 8.98   Max: 40.2
Current: 9.76

During the past 7 years, the highest EV-to-EBITDA of Vineet Laboratories was 40.20. The lowest was 4.81. And the median was 8.98.

BOM:543298's EV-to-EBITDA is ranked better than
67.8% of 1289 companies
in the Chemicals industry
Industry Median: 14.23 vs BOM:543298: 9.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Vineet Laboratories's stock price is ₹52.01. Vineet Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹2.870. Therefore, Vineet Laboratories's PE Ratio for today is 18.12.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Vineet Laboratories EV-to-EBITDA Historical Data

The historical data trend for Vineet Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories EV-to-EBITDA Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial - - - 4.38 9.63

Vineet Laboratories Quarterly Data
Mar17 Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.31 9.63 17.44 7.47 8.38

Competitive Comparison of Vineet Laboratories's EV-to-EBITDA

For the Chemicals subindustry, Vineet Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vineet Laboratories's EV-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's EV-to-EBITDA falls into.



Vineet Laboratories EV-to-EBITDA Calculation

Vineet Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=874.586/89.545
=9.77

Vineet Laboratories's current Enterprise Value is ₹875 Mil.
Vineet Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vineet Laboratories  (BOM:543298) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Vineet Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=52.01/2.870
=18.12

Vineet Laboratories's share price for today is ₹52.01.
Vineet Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.870.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Vineet Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Vineet Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Vineet Laboratories (BOM:543298) Business Description

Traded in Other Exchanges
Address
5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines